Nvidia stock rises ahead of results, Foot Locker and Peloton tank, and other stocks on the move

by user

[ad_1]

Here are some of the biggest movers of the day:

Stock gainers:

Nvidia shares
NVDA,
+2.24%

rose 2%, ahead of its eagerly awaited results after the close. Cathie Wood’s ARK Invest sold stock in the graphics chip maker on Tuesday, according to a fund disclosure.

Netflix Inc.’s stock
NFLX,
+5.22%

rose 5.6% to lead S&P 500 gainers, after Oppenheimer analysts said paid programming and advertising should boost revenue by about 40% through fiscal 2025 from fiscal 2022.

United Parcel Services Inc.‘s stock
UPS,
+1.13%

added 1% after workers at the deliveries and logistics company voted for a new contract.

Abercrombie & Fitch Co.’s
ANF,
+23.86%

soared 25% Wednesday, after the teen clothing retailer blew past estimates for the second quarter and raised guidance.

Novavax stock
NVAX,
+0.53%

rose 0.4%, after surging 13% on Tuesday when it said its COVID-19 vaccine was effective against a variant responsible for most cases right now in the U.S. and Europe.

Alphabet Inc. Class A stock
GOOGL,
+2.63%

was up 2.8% to $132.75 on Wednesday morning. If the gains hold to the end of the session, the stock will be at its highest close since April 8, 2022 when it ended at $133.29, according to Dow Jones Market Data.

Bath & Body Works Inc.’s stock
BBWI,
+2.12%

rose 2% after the Victoria’s Secret spinoff beat profit forecasts for the second quarter, offsetting a sales miss.

The stock of VCI Global Ltd. 
VCIG,
+72.08%
,
 a Malaysian consulting group, rose 70% Wednesday, after the company announced a collaboration with Microsoft Azure OpenAI services
MSFT,
+1.71%

Amazon.com Inc.’s stock
AMZN,
+0.57%

rose 0.6%, after Loop Capital’s Rob Sanderson lifted his price target to $200 from $180 and said investors aren’t giving Amazon enough credit for the potential of its AWS cloud-computing business.

Apellis Pharmaceuticals Inc.’s stock
APLS,
+30.95%

soared 31% after the company identified a potential cause for a rare but serious side effect linked with its Syfovre injection for age-related macular degeneration.

Gilead Sciences Inc.’s stock
GILD,
+1.11%
,
 Arcus Biosciences Inc. 
RCUS,
+27.33%

 and iTeos Therapeutics Inc. 
ITOS,
+33.19%

 rose sharply after Roche AG
ROG,
+3.75%

said there had been an “inadvertent disclosure” of interim data from a study of its anti-TIGIT therapy tiragolumab in non-small cell lung cancer. The news was viewed as positive for other anti-TIGIT treatments.

Stock decliners:

AMC Entertainment stock
AMC,
-9.78%

fell 8%, after an 18% drop on Tuesday. A reverse stock split is planned on Wednesday, to be followed by the conversion of the APE preferred shares.

Shares of La-Z-Boy Inc.
LZB,
-1.91%

fell 3% after the home-furniture maker topped Wall Street views for its fiscal first quarter but said that it expect its industry “to remain challenged.”

Peloton Interactive
PTON,
-23.25%

fell 25% after the exercise-machine vendor came up short with its revenue outlook for the latest quarter while disclosing that a bike recall has had a greater-than-expected impact on the business.

Foot Locker
FL,
-31.70%

slid 33.5% after the sporting goods retailer swung to a loss in the second-quarter, lowered its full-year guidance and said it’s suspending its quarterly dividend to conserve cash. The news sent Nike Inc.’s stock
NKE,
-3.51%

down 3.6% to lead S&P 500 decliners, while the stock of Dick’s Sporting Goods
DKS,
-2.73%
,
which had disappointing earnings on Tuesday, fell 2.5%.

Mallinckrodt PLC’s stock
MNK,
-20.09%

slid 17% after it announced that it would again file for Chapter 11 bankruptcy protection as it struggles with opioid-related settlements.

[ad_2]

Source link

Related Posts

Leave a Review

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy